mitiglinide has been researched along with c-peptide in 1 studies
| Studies (mitiglinide) | Trials (mitiglinide) | Recent Studies (post-2010) (mitiglinide) | Studies (c-peptide) | Trials (c-peptide) | Recent Studies (post-2010) (c-peptide) |
|---|---|---|---|---|---|
| 120 | 30 | 50 | 9,053 | 1,632 | 2,445 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujioka, Y; Inoue, K; Izawa, S; Kato, M; Matsuzawa, K; Nakanishi, R; Ohkura, H; Ohkura, T; Shiochi, H; Sumi, K; Taniguchi, S; Yamamoto, K; Yamamoto, N | 1 |
1 trial(s) available for mitiglinide and c-peptide
| Article | Year |
|---|---|
The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical study.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Humans; Hypoglycemic Agents; Insulin; Isoindoles; Male; Middle Aged; Molecular Targeted Therapy; Postprandial Period; Proinsulin; Sulfonylurea Compounds; Triglycerides | 2013 |